InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (19 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
19
T+90 hit rate
40%
T+90 mean return
-10.3%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Enright Patrick G, Director. Insider active across 5 companies, notably Vera Therapeutics, Inc.. Aggregated, 36 filings have been published. Split: 5 buys · 19 sells. Total volume traded: €19.1m. History available since 29 July 2021. The latest transaction was filed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Enright Patrick G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations36 total
1,605 shares0Ordinary SharesSEC:0001253886-26-000008:0
1,236,631 sharesCommon StockSEC:0001628280-26-005904:0
5,000 shares0Ordinary SharesSEC:0001253886-26-000002:0
5,882 shares@ US$42.501.3% of flowClass A Common StockSEC:0001193125-25-319649:0
Canonical exit: 11 Mar 2026 (T+90)
105,265 shares@ US$19.00100.0% of flowCommon StockSEC:0001193125-25-238326:0
Canonical exit: 7 Jan 2026 (T+90)
3,507 shares0Ordinary SharesSEC:0001765581-25-000092:0
69,798 shares@ US$20.86837.5% of flowClass A Common StockSEC:0000950170-25-090110:0
Canonical exit: 21 Sept 2025 (T+90)
1,310,589 sharesCommon StockSEC:0001415889-24-024046:0
723,812 sharesCommon StockSEC:0001104659-24-100333:0
3,731 shares0Ordinary SharesSEC:0001765581-24-000080:0
3,075 shares0Ordinary SharesSEC:0001765581-23-000078:0
1,714,285 shares@ US$7.0071.8% of flowClass A Common StockSEC:0000899243-23-004345:0
Canonical exit: 7 May 2023 (T+90)
2,905 shares@ US$149.178647.3% of flowOrdinary SharesSEC:0001765581-22-000126:0
2,561 shares0Ordinary SharesSEC:0001765581-22-000084:0
333,333 shares@ US$15.000.12% mcap100.0% of flowClass A Common StockSEC:0000899243-22-013596:0
Canonical exit: 11 May 2022 (T+90)
2,000 shares@ US$137.7535.8% of flowOrdinary SharesSEC:0001765581-21-000114:0
2,246 shares0Ordinary SharesSEC:0001765581-21-000069:0
2,187,504 sharesClass A Common StockSEC:0001209191-21-033809:0
294 sharesOrdinary SharesSEC:0001209191-16-098131:0
1,698 sharesOrdinary SharesSEC:0001209191-16-098131:1
2,594 sharesOrdinary SharesSEC:0001209191-16-098131:2
3,159 sharesOrdinary SharesSEC:0001209191-16-098131:3
1,666 sharesOrdinary SharesSEC:0001209191-16-098131:4
393 sharesOrdinary SharesSEC:0001209191-16-098131:5
6 sharesOrdinary SharesSEC:0001209191-16-098131:6
25 of 36 declarations
About Enright Patrick G
Enright Patrick G is Administrateur of Jazz Pharmaceuticals plc, Vera Therapeutics, Inc., Zenas BioPharma, Inc., Veradermics, Inc and BioAge Labs, Inc. Across 35 total filings, the 35 sampled filings run from 2016-01-07 to 2026-02-05, with EUR 18696785 in buys and EUR 422972 in sales, and the most common transaction nature being sale.
